Crawford four-month appraisal
This article was originally published in The Tan Sheet
Acting FDA Commissioner Lester Crawford, PhD, "is doing an awesome job," HHS Secretary Tommy Thompson tells AdvaMed board members June 20 in Washington, D.C. "He is out there to make changes. He is already making more changes in the short couple [of] months he's been here...realigning, reorganizing, putting in the risk assessment system....Whether or not he's going to get to be the commissioner I can't tell you. That's a decision for the President. But I can assure you, until the final commissioner is appointed by the President, this man is in charge, this man is going to continue to make changes"...
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.